![James Caruso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Caruso
Vorstandsvorsitzender bei
CELLECTAR BIOSCIENCES, INC.
Vermögen: 36 543 $ am 31.05.2026
Profil
James V.
Caruso is the founder of Hip Innovation Technology LLC, founded in 2010, where the title held is Director since 2015.
The current job is President, Chief Executive Officer & Director at Cellectar Biosciences, Inc., starting in 2015.
Former jobs include Senior Vice President-Sales & Marketing at Bone Care International, Inc. from 2002 to 2005; Chief Commercial Officer & Executive VP at Allos Therapeutics, Inc. from 2006 to 2010; Vice President-Neuroscience Specialty Sales at Novartis Corp.
from 2001 to 2002; Vice President-Sales at Knoll Pharmaceutical Co. from 2000 to 2001; and Vice President-Primary & Specialty Sales at BASF Pharma Ltd. from 2000 to 2001.
Education includes undergraduate studies at the University of Nevada.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.05.2026 | 11.638 ( 0,15 % ) | 36 543 $ | 31.05.2026 |
Aktive Positionen von James Caruso
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Vorstandsvorsitzender | 15.06.2015 |
Hip Innovation Technology LLC
 Hip Innovation Technology LLC Medical DistributorsDistribution Services Sells hip implant systems and components | Gründer | 01.08.2010 |
Ehemalige bekannte Positionen von James Caruso
| Unternehmen | Position | Ende |
|---|---|---|
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Corporate Officer/Principal | 24.08.2010 |
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Vertrieb & Marketing | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Vertrieb & Marketing | 01.06.2002 |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces excipients and active ingredients | Vertrieb & Marketing | 01.05.2001 |
Knoll Pharmaceutical Co. | Vertrieb & Marketing | 01.01.2001 |
Ausbildung von James Caruso
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
43
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bone Care International, Inc.
Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Hip Innovation Technology LLC
Hip Innovation Technology LLC Medical DistributorsDistribution Services Sells hip implant systems and components | Distribution Services |
BASF Pharma Ltd.
BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces excipients and active ingredients | Health Technology |
University of Nevada
 University of Nevada Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Knoll Pharmaceutical Co. | |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
